|
HealthCor Partners Management, L.P. ("HealthCor Partners"), with approximately $300 million of assets dedicated to private equity, invests primarily in later-stage developmental and growing mid-sized companies across all sectors of the healthcare and life sciences industry. HealthCor Partners also selectively targets "special situation" opportunities in the healthcare and life sciences industry.
HealthCor Partners is an affiliate of HealthCor Management, L.P. ("HealthCor Management"), a leading investment adviser to healthcare and life sciences hedge funds. HealthCor Management is known for its strong track record and fundamental, research-driven investment approach. Together, HealthCor Partners and HealthCor Management comprise the HealthCor Group, which with over $3.0 billion of assets under management, is one of the largest healthcare and life sciences investment management firms in the United States.
In addition to being able to leverage the HealthCor Group's research and public equity expertise, HealthCor Partners is differentiated from other middle-market healthcare or life sciences private equity firms by the breadth of its investment focus; which includes diagnostics, medtech and devices, therapeutics and healthcare services. This broad focus not only provides fund diversification, but also creates a deeper context for identifying and understanding the continual interactions among the different sectors of the healthcare and life sciences industry. HealthCor Partners believes its comprehensive view of this interplay provides important and meaningful insights in evaluating, making and monitoring its investments.
|
| |
|
BREAKING NEWS
BAXTER AND APATECH ANNOUNCE DEFINITIVE AGREEMENT: Baxter to Acquire All Outstanding Equity of ApaTech, Including ACTIFUSE
DEERFIELD, Ill. and LONDON, U.K., March 1, 2010 – Baxter International Inc. (NYSE:BAX), a global, diversified healthcare company, and ApaTech, a private equitybacked, U.K.-based orthobiologic products company, today announced a definitive agreement whereby Baxter will acquire all of the outstanding equity of ApaTech for total consideration of up to $330 million.
|
|
| |
|